News story about the drug company's decision to stop selling rofecoxib after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke. (September 30, 2004)
Hits to Merck Withdraws Arthritis Drug Vioxx:
0
| Rating:
0
| Votes:
0
